Journal of Neuroinflammation,
Год журнала:
2023,
Номер
20(1)
Опубликована: Сен. 30, 2023
Neuroinflammation
is
one
of
the
most
important
pathogeneses
in
secondary
brain
injury
after
traumatic
(TBI).
Neutrophil
extracellular
traps
(NETs)
forming
neutrophils
were
found
throughout
tissue
TBI
patients
and
elevated
plasma
NET
biomarkers
correlated
with
worse
outcomes.
However,
biological
function
underlying
mechanisms
NETs
TBI-induced
neural
damage
are
not
yet
fully
understood.
Here,
we
used
Cl-amidine,
a
selective
inhibitor
to
investigate
role
TBI.Controlled
cortical
impact
model
was
performed
establish
TBI.
2'3'-cGAMP
(an
activator
stimulating
Interferon
genes
(STING)),
C-176
(a
STING
inhibitor),
Kira6
[a
selectively
phosphorylated
inositol-requiring
enzyme-1
alpha
[IRE1α]
inhibitor]
administrated
explore
mechanism
by
which
promote
neuroinflammation
neuronal
apoptosis
Peptidyl
arginine
deiminase
4
(PAD4),
an
essential
enzyme
for
neutrophil
trap
formation,
overexpressed
adenoviruses
cortex
mice
1
day
before
The
short-term
neurobehavior
tests,
magnetic
resonance
imaging
(MRI),
laser
speckle
contrast
(LSCI),
Evans
blue
extravasation
assay,
Fluoro-Jade
C
(FJC),
TUNEL,
immunofluorescence,
enzyme-linked
immunosorbent
assay
(ELISA),
western
blotting,
quantitative-PCR
this
study.Neutrophils
form
presenting
circulation
at
3
days
Cl-amidine
treatment
improved
neurological
functions,
reduced
cerebral
lesion
volume,
edema,
restored
blood
flow
(CBF)
In
addition,
exerted
neuroprotective
effects
attenuating
BBB
disruption,
inhibiting
immune
cell
infiltration,
alleviating
death
Moreover,
inhibited
microglia/macrophage
pro-inflammatory
polarization
promoted
anti-inflammatory
Mechanistically,
ligand
abolished
neuroprotection
via
IRE1α/ASK1/JNK
signaling
pathway
Importantly,
overexpression
PAD4
promotes
or
IRE1α
effectively
neurodestructive
TBI.Altogether,
first
demonstrate
that
inhibition
ameliorated
neuroinflammation,
apoptosis,
deficits
STING-dependent
Thus,
may
provide
promising
therapeutic
approach
early
management
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Сен. 22, 2023
Abstract
Microglia
activation
is
observed
in
various
neurodegenerative
diseases.
Recent
advances
single-cell
technologies
have
revealed
that
these
reactive
microglia
were
with
high
spatial
and
temporal
heterogeneity.
Some
identified
specific
states
correlate
pathological
hallmarks
are
associated
functions.
both
exert
protective
function
by
phagocytosing
clearing
protein
aggregates
play
detrimental
roles
due
to
excessive
uptake
of
aggregates,
which
would
lead
microglial
phagocytic
ability
impairment,
neuroinflammation,
eventually
neurodegeneration.
In
addition,
peripheral
immune
cells
infiltration
shapes
into
a
pro-inflammatory
phenotype
accelerates
disease
progression.
also
act
as
mobile
vehicle
propagate
aggregates.
Extracellular
vesicles
released
from
autophagy
impairment
all
contribute
progression
Thus,
enhancing
phagocytosis,
reducing
microglial-mediated
inhibiting
exosome
synthesis
secretion,
promoting
conversion
considered
be
promising
strategies
for
the
therapy
Here
we
comprehensively
review
biology
diseases,
including
Alzheimer’s
disease,
Parkinson’s
multiple
system
atrophy,
amyotrophic
lateral
sclerosis,
frontotemporal
dementia,
progressive
supranuclear
palsy,
corticobasal
degeneration,
dementia
Lewy
bodies
Huntington’s
disease.
We
summarize
possible
microglia-targeted
interventions
treatments
against
diseases
preclinical
clinical
evidence
cell
experiments,
animal
studies,
trials.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Фев. 16, 2024
Abstract
The
human
gastrointestinal
tract
is
populated
with
a
diverse
microbial
community.
vast
genetic
and
metabolic
potential
of
the
gut
microbiome
underpins
its
ubiquity
in
nearly
every
aspect
biology,
including
health
maintenance,
development,
aging,
disease.
advent
new
sequencing
technologies
culture-independent
methods
has
allowed
researchers
to
move
beyond
correlative
studies
toward
mechanistic
explorations
shed
light
on
microbiome–host
interactions.
Evidence
unveiled
bidirectional
communication
between
central
nervous
system,
referred
as
“microbiota–gut–brain
axis”.
microbiota–gut–brain
axis
represents
an
important
regulator
glial
functions,
making
it
actionable
target
ameliorate
development
progression
neurodegenerative
diseases.
In
this
review,
we
discuss
mechanisms
As
provides
essential
cues
microglia,
astrocytes,
oligodendrocytes,
examine
communications
microbiota
these
cells
during
healthy
states
Subsequently,
diseases
using
metabolite-centric
approach,
while
also
examining
role
microbiota-related
neurotransmitters
hormones.
Next,
targeting
intestinal
barrier,
blood–brain
meninges,
peripheral
immune
system
counteract
dysfunction
neurodegeneration.
Finally,
conclude
by
assessing
pre-clinical
clinical
evidence
probiotics,
prebiotics,
fecal
transplantation
A
thorough
comprehension
will
foster
effective
therapeutic
interventions
for
management
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Окт. 13, 2023
Astroglia
are
a
broad
class
of
neural
parenchymal
cells
primarily
dedicated
to
homoeostasis
and
defence
the
central
nervous
system
(CNS).
contribute
pathophysiology
all
neurological
neuropsychiatric
disorders
in
ways
that
can
be
either
beneficial
or
detrimental
disorder
outcome.
Pathophysiological
changes
astroglia
primary
secondary
result
gain
loss
functions.
respond
external,
non-cell
autonomous
signals
associated
with
any
form
CNS
pathology
by
undergoing
complex
variable
their
structure,
molecular
expression,
function.
In
addition,
internally
driven,
cell
astroglial
innate
properties
lead
pathologies.
Astroglial
is
complex,
different
pathophysiological
states
phenotypes
context-specific
vary
disorder,
disorder-stage,
comorbidities,
age,
sex.
Here,
we
classify
into
(i)
reactive
astrogliosis,
(ii)
atrophy
function,
(iii)
degeneration
death,
(iv)
astrocytopathies
characterised
aberrant
forms
drive
disease.
We
review
across
spectrum
human
diseases
disorders,
including
neurotrauma,
stroke,
neuroinfection,
autoimmune
attack
epilepsy,
as
well
neurodevelopmental,
neurodegenerative,
metabolic
disorders.
Characterising
cellular
mechanisms
represents
new
frontier
identify
novel
therapeutic
strategies.
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Фев. 22, 2023
Alzheimer’s
disease
(AD)
is
defined
as
a
severe
chronic
degenerative
neurological
in
human.
The
pathogenic
mechanism
of
AD
has
been
convincingly
elucidated
by
the
“amyloid
cascade
hypothesis”
with
main
focus
pathological
accretion
β-amyloid
(Aβ)
peptides
outside
cell.
However,
increasing
evidence
suggests
that
this
hypothesis
weak
explaining
pathogenesis
AD.
Neuroinflammation
crucial
development
AD,
which
proven
elevated
levels
inflammatory
markers
and
identification
risk
genes
relevant
to
innate
immune
function.
Here,
we
summarize
effects
microglia-mediated
neuroinflammation
on
focusing
temporal
spatial
changes
microglial
phenotype,
interactions
among
microglia,
Aβ,
tau,
neurons,
prospects
recent
advances
diagnostic
therapeutic
target
Cell stem cell,
Год журнала:
2023,
Номер
30(2), С. 120 - 136
Опубликована: Фев. 1, 2023
Adult
hippocampal
neurogenesis
(AHN)
drops
sharply
during
early
stages
of
Alzheimer's
disease
(AD),
via
unknown
mechanisms,
and
correlates
with
cognitive
status
in
AD
patients.
Understanding
AHN
regulation
could
provide
a
framework
for
innovative
pharmacological
interventions.
We
here
combine
molecular,
behavioral,
clinical
data
critically
discuss
the
multicellular
complexity
niche
relation
to
pathophysiology.
further
present
roadmap
toward
better
understanding
role
by
probing
promises
caveats
latest
technological
advancements
field
addressing
conceptual
methodological
challenges
ahead.
Journal of Neurochemistry,
Год журнала:
2023,
Номер
165(4), С. 487 - 520
Опубликована: Март 13, 2023
Abstract
Over
30
million
people
suffer
from
the
consequences
of
ischemic
stroke.
The
precise
molecular
mechanism
neuronal
damage
during
stroke
remains
unclear;
therefore,
effective
treatment
post‐ischemic
a
critical
challenge.
Recently,
iron
has
emerged
as
crucial
factor
in
post‐reperfusion
injuries,
participating
cell
peroxidation,
excitotoxicity,
and
distinctive
death
pathway,
namely,
ferroptosis.
Since
is
tightly
regulated
brain
important
for
functions,
imbalance
its
metabolism,
including
overload
deficiency,
been
shown
to
impact
outcomes.
This
review
summarizes
current
understanding
pathological
events
associated
with
discusses
relevant
drug
development.
image
Nature,
Год журнала:
2024,
Номер
628(8006), С. 195 - 203
Опубликована: Март 13, 2024
Abstract
Sustained
smouldering,
or
low-grade
activation,
of
myeloid
cells
is
a
common
hallmark
several
chronic
neurological
diseases,
including
multiple
sclerosis
1
.
Distinct
metabolic
and
mitochondrial
features
guide
the
activation
diverse
functional
states
2
However,
how
these
act
to
perpetuate
inflammation
central
nervous
system
unclear.
Here,
using
multiomics
approach,
we
identify
molecular
signature
that
sustains
microglia
through
complex
I
activity
driving
reverse
electron
transport
production
reactive
oxygen
species.
Mechanistically,
blocking
in
pro-inflammatory
protects
against
neurotoxic
damage
improves
outcomes
an
animal
disease
model
vivo.
Complex
potential
therapeutic
target
foster
neuroprotection
inflammatory
disorders
3
Nature Immunology,
Год журнала:
2023,
Номер
24(8), С. 1382 - 1390
Опубликована: Июль 27, 2023
Abstract
Microglia,
the
macrophages
of
brain
parenchyma,
are
key
players
in
neurodegenerative
diseases
such
as
Alzheimer’s
disease.
These
cells
adopt
distinct
transcriptional
subtypes
known
states.
Understanding
state
function,
especially
human
microglia,
has
been
elusive
owing
to
a
lack
tools
model
and
manipulate
these
cells.
Here,
we
developed
platform
for
modeling
microglia
states
vitro.
We
found
that
exposure
stem-cell-differentiated
synaptosomes,
myelin
debris,
apoptotic
neurons
or
synthetic
amyloid-beta
fibrils
generated
diversity
mapped
gene
signatures
identified
including
disease-associated
enriched
diseases.
Using
new
lentiviral
approach,
demonstrated
transcription
factor
MITF
drives
signature
highly
phagocytic
state.
Together,
enable
manipulation
functional
interrogation
microglial
both
homeostatic
disease-relevant
contexts.
Nature Communications,
Год журнала:
2023,
Номер
14(1)
Опубликована: Июнь 26, 2023
Abstract
Dopaminergic
cell
loss
due
to
the
accumulation
of
α-syn
is
a
core
feature
pathogenesis
Parkinson
disease.
Neuroinflammation
specifically
induced
by
α-synuclein
has
been
shown
exacerbate
neurodegeneration,
yet
role
central
nervous
system
(CNS)
resident
macrophages
in
this
process
remains
unclear.
We
found
that
specific
subset
CNS
macrophages,
border-associated
(BAMs),
play
an
essential
mediating
related
neuroinflammation
their
unique
as
antigen
presenting
cells
necessary
initiate
CD4
T
response
whereas
MHCII
presentation
on
microglia
had
no
effect
neuroinflammation.
Furthermore,
expression
led
expansion
macrophage
numbers
and
damage-associated
activation
state.
Through
combinatorial
approach
single-cell
RNA
sequencing
depletion
experiments,
we
played
immune
recruitment,
infiltration,
presentation.
were
identified
post-mortem
PD
brain
close
proximity
cells.
These
results
point
for
disease
through
orchestration
α-synuclein-mediated
neuroinflammatory
response.